Allopurinol |
Xanthine oxidase inhibition |
Johnson et al.
53
|
Yes |
|
|
Rashid and William‐Olsson
54
|
|
|
|
Tabayashi et al.
55
|
|
|
|
Gavin and Struthers
56
|
No |
Losartan |
Uricosuric |
Hoieggen et al.
15
|
Yes |
|
Insulin‐sensitizing |
|
|
Estrogen + progestin |
Uricosuric |
Simon et al.
18
|
No |
Atorvastatin |
Uricosuric |
Athyros et al.
16
|
Yes |
|
Insulin‐sensitizing |
Milionis et al.
58
|
|
Sulfinpyrazone (antiplatelet) |
Uricosuric |
The Anturane Reinfarction Trial. N Engl J Med. 1978 |
Yes |
Cilostazol (antiplatelet) |
Uricosuric |
Mitsuhashi et al. Endocr J. 2004 |
Yes |
Fenoflbrate (PPAR‐α) |
Uricosuric |
Elisaf et al. J Cardiovasc Pharmacol. 1999 |
? |
|
PPAR agonist |
Seber et al. Diabetes Res Clin Pract. 2005 |
|
|
Insulin‐sensitizing |
|
|
Rosiglitazone (PPAR‐γ) |
PPAR agonist |
Tsunoda et al. Am J Hypertens. 2002 |
? |
|
Insulin‐sensitizing |
|
|
Metformin |
Insulin‐sensitizing |
Gokcel et al. Diabetes Obes Metab. 2002 |
? |
Sibutramine‐orlistat (weight loss) |
Insulin‐sensitizing |
Gokcel et al. Diabetes Obes Metab. 2002 |
? |
Low‐energy diet |
Insulin‐sensitizing |
Tsunoda et al. Am J Hypertens. 2002 |
? |
Amlodipine |
Uricosuric |
Sennesael et al. Am J Kidney Dis. 1996 |
? |
|
|
Chanard et al. Nephrol Dial Transplant. 2003 |
|
PPAR=peroxisome proliferator‐activated receptors; ?=potential, but still unproven; *attributed effect on renal and cardiovascular disease |